BioMark Diagnostics

About:

BioMark Diagnostics is an oncology-focused company.

Website: https://www.biomarkdiagnostics.com/

Top Investors: Mitacs, National Research Council of Canada Industrial Research Assistance Program, Brain Canada, Canadian Cancer Society, MEDTEQ+

Description:

BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites. They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals to help commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers.

Total Funding Amount:

$3.72M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Richmond, Quebec, Canada

Founded Date:

2006-01-01

Contact Email:

info(AT)biomarkdiagnostics.com

Founders:

Rashid Ahmed Bux

Number of Employees:

1-10

Last Funding Date:

2024-04-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai